Publications scientifiques en 2013

  1. Zeitoun JD, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, et al. Functional digestive symptoms and quality of life in patients with ehlers-danlos syndromes: results of a national cohort study on 134 patients. PLoS One 2013;8:e80321.
  2. Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, et al. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. Br J Cancer 2013;109:3057-66.
  3. Kartheuser AH, Leonard DF, Penninckx F, Paterson HM, Brandt D, Remue C, et al. Waist circumference and waist/hip ratio are better predictive risk factors for mortality and morbidity after colorectal surgery than body mass index and body surface area. Ann Surg 2013;258:722-30.
  4. Lefevre JH, Rousseau A, Svrcek M, Parc Y, Simon T, Tiret E, et al. A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design. BMC Cancer 2013;13:417.
  5. Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, et al. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy. World J Surg 2013;37:2647-54.
  6. Vuarnesson H, Lupinacci RM, Semoun O, Svrcek M, Julié C, Balladur P, et al. Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. Eur J Surg Oncol 2013;39:1116-21.
  7. Radais F, Zaanan A, Lefévre JH, Fléjou JF, Balladur P, Paye F, et al. Biomarkers and prognosis after R0 resection of colorectal liver metastases. Hepatogastroenterology 2013;60:1469-75.
  8. Chéreau N, Lefevre JH, Lefrancois M, Chafai N, Parc Y, Tiret E. Management of malignant left colonic obstruction: is an initial temporary colostomy followed by surgical resection a better option? Colorectal Dis 2013;15:e646-53.
  9. Paye F, Lupinacci RM, Kraemer A, Lescot T, Chafaï N, Tiret E, et al. Surgical treatment of severe pancreatic fistula after pancreaticoduodenectomy by wirsungostomy and repeat pancreatico-jejunal anastomosis. Am J Surg 2013;206:194-201.
  10. Décarie PO, Paye F, Arrivé L. Cystic dystrophy of the gastroduodenal wall in heterotopic pancreas. Clin Res Hepatol Gastroenterol 2013;37:551-2.
  11. Pommaret E, Vienne A, Lefevre JH, Sogni P, Florent C, Desaint B, et al. Prevalence and risk factors for adenomas in the ileal pouch and the afferent loop after restorative proctocolectomy for patients with familial adenomatous polyposis. Surg Endosc 2013;27:3816-22.
  12. Canard G, Lefevre JH, Parc Y. Management of duodenal perforation or fistula by intubation with the Levy drain. Surgical technique and postoperative management. J Visc Surg 2013;150:115-9.
  13. Chéreau N, Lefevre JH, Meurette G, Mourra N, Shields C, Parc Y, et al. Surgical resection of retrorectal tumours in adults: long-term results in 47 patients. Colorectal Dis 2013;15:e476-82.
  14. Robb WB, Messager M, Goere D, Pichot-Delahaye V, Lefevre JH, Louis D, et al. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection. JAMA Surg 2013;148:624-31.
  15. Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013;62:812-23.
  16. Chirica M, Tranchart H, Tan V, Faron M, Balladur P, Paye F. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation. Ann Surg Oncol 2013;20:2405-12.
  17. Lefèvre JH, Faron M, Drouin SJ, Glanard A, Chartier-Kastler E, Parc Y, et al. Évaluation comparative et objective de la production scientifique des services hospitaliers au sein de l’Assistance publique-Hôpitaux de Paris: analyse des scores SIGAPS. Rev Med Interne 2013;34:342-8.
  18. Belhassan M, Zeitoun JD, Lefevre JH, Charachon A, Amiot A, Le Baleur Y, et al. Infliximab infusion time in patients with inflammatory bowel diseases: is longer really safer? Clin Res Hepatol Gastroenterol 2013;37:189-92.
  19. Tranchart H, Lefèvre JH, Svrcek M, Flejou JF, Tiret E, Parc Y. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer? Ann Surg Oncol 2013;20:1551-9.
  20. Mariette C, Bruyère E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, et al. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery? Ann Surg Oncol 2013;20:1240-9.
  21. Turrini O, Paye F, Bachellier P, Sauvanet A, Sa Cunha A, Le Treut YP, et al. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. Eur J Surg Oncol 2013;39:171-8.
  22. Sourrouille I, Coulet F, Lefevre JH, Colas C, Eyries M, Svrcek M, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. Fam Cancer 2013;12:27-33.
  23. Rey-Jouvin C, Sellam J, Chafai N, Yazid L, Miquel A, Berenbaum F. Clinical image: Spondylodiscitis due to a fistula between L5-S1 disc and colon. Joint Bone Spine 2013;80:100-1.